The modeling study predicts the rate of drug-resistant BSIs will rise sharply in Europe over the next 5 years, driven ...
The intravenous formulation of fosfomycin has a novel mechanism of action an no known cross-resistance to other antibiotic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback